2026-03-12 March 2026 release

PHIPO March 2026 release

This release contains the following changes:

New terms

• resistance to sodium dodecyl sulfate (PHIPO:0001450)
• sensitive to acidity (PHIPO:0001451)

Full Changelog: v2026-01-26...v2026-03-12

2026-01-26 January 2026 release

PHIPO January 2026 release

This release contains the following changes:

New terms

• sensitive to ammonium (PHIPO:0001449)

Contributors

• @aleixpuigb: replaced the URL for the ChEBI slim ontology with a PURL (#443)

Full Changelog: v2025-10-29...v2026-01-26

2025-10-29 October 2025 release

PHIPO October 2025 release

This release contains the following changes:

Renamed terms

• PHIPO:0001139 renamed to 'decreased number of septa in asexual spore'
• PHIPO:0001439 renamed to 'increased number of septa in asexual spore'

Full Changelog: v2025-07-29...v2025-10-29

2025-07-29 July 2025 release

PHIPO July 2025 release

This release contains the following changes:

• Ensure that oboInOwl annotations are used in the OWL release format so that the created_by and creation_date tags are properly represented in the OBO release format. (57254ac)

New terms

• abnormal biological process phenotype (PHIPO:0001442)
• abnormal mycotoxin biosynthesis (PHIPO:0001441)
• abnormal deoxynivalenol biosynthesis (PHIPO:0001443)
• sensitive to heat stress (PHIPO:0001444)
• decreased level of deoxynivalenol (PHIPO:0001445)
• reduced hyphal branching (PHIPO:0001446)
• increased level of deoxynivalenol (PHIPO:0001447)
• restored pathogenicity (PHIPO:0001448)

Full Changelog: v2024-08-29...v2025-07-29

2024-08-29 August 2024 release

PHIPO August 2024 release

This release contains the following changes since the previous release (4 April 2024).

New terms

• increased number of septum in asexual spore (PHIPO:0001439) (#431)
• increased number of nuclei in asexual spore (PHIPO:0001440) (#432)

Full Changelog: v2024-04-04...v2024-08-29

2024-04-04 April 2024 release

PHIPO April 2024 release

This release contains the following changes since the previous release (31 January 2024).

New terms

• resistance to dalfopristin (PHIPO:0001411)
• sensitive to dalfopristin (PHIPO:0001412)
• normal growth on dalfopristin (PHIPO:0001413)
• resistance to thifluzamide (PHIPO:0001414)
• sensitive to thifluzamide (PHIPO:0001415)
• normal growth on thifluzamide (PHIPO:0001416)
• resistance to penflufen (PHIPO:0001417)
• sensitive to penflufen (PHIPO:0001418)
• normal growth on penflufen (PHIPO:0001419)
• resistance to flutolanil (PHIPO:0001420)
• sensitive to flutolanil (PHIPO:0001421)
• normal growth on flutolanil (PHIPO:0001422)
• resistance to imazalil (PHIPO:0001423)
• sensitive to imazalil (PHIPO:0001424)
• normal growth on imazalil (PHIPO:0001425)
• normal growth on fludioxonil (PHIPO:0001426)
• abnormal hyphal branching (PHIPO:0001427)
• normal growth on brefeldin A (PHIPO:0001428)
• normal growth on fluconazole (PHIPO:0001429)
• resistance to ipconazole (PHIPO:0001430)
• sensitive to ipconazole (PHIPO:0001431)
• normal growth on ipconazole (PHIPO:0001432)
• resistance to cyprodinil (PHIPO:0001433)
• sensitive to cyprodinil (PHIPO:0001434)
• normal growth on cyprodinil (PHIPO:0001435)
• normal growth on caspofungin (PHIPO:0001436)
• normal growth on terbinafine (PHIPO:0001447)
• normal growth on bifonazole (PHIPO:0001448)

Term hierarchy changes

• 'hyphal hyper branching' (PHIPO:0001153) child of 'abnormal hyphal branching' (PHIPO:0001427)

Full Changelog: v2024-01-31...v2024-04-04

2024-01-31 January 2024 release

PHIPO January 2024 release

This release contains the following changes since the previous release (30 November 2023).

New terms

• resistance to pyrisoxazole (PHIPO:0001388) (#419)
• sensitive to pyrisoxazole (PHIPO:0001389) (#419)
• normal growth on pyrisoxazole (PHIPO:0001390) (#419)
• resistance to metconazole (PHIPO:0001391) (#419)
• sensitive to metconazole (PHIPO:0001392) (#419)
• normal growth on metconazole (PHIPO:0001393) (#419)
• resistance to trifloxystrobin (PHIPO:0001394) (#419)
• sensitive to trifloxystrobin (PHIPO:0001395) (#419)
• normal growth on trifloxystrobin (PHIPO:0001396) (#419)
• sensitive to cell wall stress (PHIPO:0001397) (#427)
• sensitive to oxidative stress (PHIPO:0001398) (#428)
• resistance to flusilazole (PHIPO:0001399) (#419)
• sensitive to flusilazole (PHIPO:0001400) (#419)
• normal growth on flusilazole (PHIPO:0001401) (#419)
• resistance to mandipropamid (PHIPO:0001402) (#419)
• sensitive to mandipropamid (PHIPO:0001403) (#419)
• normal growth on mandipropamid (PHIPO:0001404) (#419)
• resistance to dimethomorph (PHIPO:0001405) (#419)
• sensitive to dimethomorph (PHIPO:0001406) (#419)
• normal growth on dimethomorph (PHIPO:0001407) (#419)
• resistance to iprovalicarb (PHIPO:0001408) (#419)
• sensitive to iprovalicarb (PHIPO:0001409) (#419)
• normal growth on iprovalicarb (PHIPO:0001410) (#419)

Term hierarchy changes

• 'sensitive to congo red' (PHIPO:0001021) has an additional parent term: 'sensitive to stress' (PHIPO:0001397) (#427)
• 'sensitive to hydrogen peroxide' (PHIPO:0000943) has an additional parent term: 'sensitive to oxidative stress' (PHIPO:0001398) (#428)

Full Changelog: v2023-11-30...v2024-01-31

2023-11-30 November 2023 release

PHIPO November 2023 release

This release contains the following changes since the previous release (11 October 2023).

New terms

• anatomical structure physical quality phenotype (PHIPO:0001373)
• increased number of resting structures (PHIPO:0001374)
• decreased number of resting structures (PHIPO:0001375)
• normal anatomical structure physical quality phenotype (PHIPO:0001376)
• normal number of resting structures (PHIPO:0001377)
• resistance to tacrolimus (PHIPO:0001378)
• sensitive to tacrolimus (PHIPO:0001379)
• normal growth on tacrolimus (PHIPO:0001380)
• sensitive to iron (PHIPO:0001381)
• resistance to fenpiclonil (PHIPO:0001382)
• sensitive to fenpiclonil (PHIPO:0001383)
• normal growth on fenpiclonil (PHIPO:0001384)
• resistance to phenamacril (PHIPO:0001385)
• sensitive to phenamacril (PHIPO:0001386)
• normal growth on phenamacril (PHIPO:0001387)

Moved terms

• normal filament morphology (PHIPO:0001206)
  • Moved under 'normal anatomical structure physical quality phenotype' (PHIPO:0001376)
• abnormal anatomical structure physical quality phenotype (PHIPO:0001221)
  • Moved under 'anatomical structure physical quality phenotype' (PHIPO:0001373)

Full Changelog: v2023-10-11...v2023-11-30

2023-10-11 October 2023 release

PHIPO October 2023 release

This release contains the following changes since the previous release (7 September 2023).

New terms

• resistance to prothioconazole (PHIPO:0001353) (#419)
• sensitive to prothioconazole (PHIPO:0001354) (#419)
• normal growth on prothioconazole (PHIPO:0001355) (#419)
• resistance to fluopyram (PHIPO:0001356) (#419)
• sensitive to fluopyram (PHIPO:0001357) (#419)
• normal growth on fluopyram (PHIPO:0001358) (#419)
• resistance to kresoxim-methyl (PHIPO:0001359) (#419)
• sensitive to kresoxim-methyl (PHIPO:0001360) (#419)
• normal growth on kresoxim-methyl (PHIPO:0001361) (#419)
• resistance to isopyrazam (PHIPO:0001362) (#419)
• sensitive to isopyrazam (PHIPO:0001363) (#419)
• normal growth on isopyrazam (PHIPO:0001364) (#419)
• resistance to bixafen (PHIPO:0001365) (#419)
• sensitive to bixafen (PHIPO:0001366) (#419)
• normal growth on bixafen (PHIPO:0001367) (#419)
• normal growth on carboxin (PHIPO:0001368) (#419)
• increased rate of hyphae formation (PHIPO:0001369) (#423)
• resistance to pyrimorph (PHIPO:0001370) (#419)
• sensitive to pyrimorph (PHIPO:0001371) (#419)
• normal growth on pyrimorph (PHIPO:0001372) (#419)

Full Changelog: v2023-09-07...v2023-10-11

2023-09-07 September 2023 release

PHIPO September 2023 release

This release contains the following changes since the previous release (3 August 2023).

New terms

• normal growth on amphotericin B (PHIPO:0001352) (#421)
• normal growth on itraconazole (PHIPO:0001351) (#422)
• resistance to triflumizole (PHIPO:0001342) (#419)
• sensitive to triflumizole (PHIPO:0001343) (#419)
• normal growth on triflumizole (PHIPO:0001344) (#419)
• resistance to bitertanol (PHIPO:0001345) (#419)
• sensitive to bitertanol (PHIPO:0001346) (#419)
• normal growth on bitertanol (PHIPO:0001347) (#419)
• resistance to pyrifenox (PHIPO:0001348) (#419)
• sensitive to pyrifenox (PHIPO:0001349) (#419)
• normal growth on pyrifenox (PHIPO:0001350) (#419)
• normal growth on thiabendazole (PHIPO:0001341) (#418)
• resistance to nocodazole (PHIPO:0001340) (#417)
• sensitive to procymidone (PHIPO:0001339) (#415)
• sensitive to thiram (PHIPO:0001338) (#414)
• sensitive to fluazinam (PHIPO:0001337) (#413)
• sensitive to myclobutanil (PHIPO:0001336) (#409)
• resistance to myclobutanil (PHIPO:0001335) (#409)
• resistance to fluazinam (PHIPO:0001334) (#413)
• resistance to thiram (PHIPO:0001333) (#414)
• resistance to procymidone (PHIPO:0001332) (#415)
• normal growth on procymidone (PHIPO:0001331) (#415)
• normal growth on thiram (PHIPO:0001330) (#414)
• normal growth on fluazinam (PHIPO:0001329) (#413)
• normal growth on myclobutanil (PHIPO:0001328) (#409)
• normal growth on iprodione (PHIPO:0001327) (#410)
• normal growth on prochloraz (PHIPO:0001326) (#411)
• normal growth on tebuconazole (PHIPO:0001325) (#412)
• normal growth on pyrimethanil (PHIPO:0001324) (#416)

Full Changelog: v2023-08-03...v2023-09-07